Literature DB >> 21850564

Preoperative FDG-PET predicts recurrence patterns in hepatocellular carcinoma.

Koji Kitamura1, Etsuro Hatano, Tatsuya Higashi, Satoru Seo, Yuji Nakamoto, Kenya Yamanaka, Taku Iida, Kojiro Taura, Kentaro Yasuchika, Shinji Uemoto.   

Abstract

PURPOSE: We investigated the usefulness of preoperative fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) as a tool for predicting recurrence patterns to select patients for liver resection as an initial surgical strategy for hepatocellular carcinoma.
METHODS: Sixty-three consecutive hepatocellular carcinoma patients undergoing FDG-PET were enrolled. They were classified according to the initial recurrence patterns (beyond the Milan criteria [MC], within the MC, and no recurrence) and the time intervals before initial postoperative recurrence (within 1 year, after 1 year or later, and no recurrence). The tumor-to-nontumor ratio (TNR) obtained by FDG-PET and survival rates were compared among the groups.
RESULTS: TNR in the recurrence within the MC group (1.9 ± 1.6) and no recurrence group (1.3 ± 1.5) was significantly lower than that in the beyond the MC group (2.9 ± 2.6). TNR was an independent predictive factor of recurrence patterns in multivariate analysis. TNR in the groups with recurrence after 1 year or later (1.6 ± 0.8) and no recurrence (1.3 ± 0.5) were significantly lower than that in the within 1-year group (3.1 ± 2.7). TNR was an independent predictive factor of the interval before initial recurrence by multivariate analysis.
CONCLUSIONS: Preoperative FDG-PET predicts hepatocellular carcinoma recurrences within the MC or no recurrence and recurrences after 1 year or later. FDG-PET may be useful for selecting appropriate patients for liver resection as an initial surgical strategy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21850564     DOI: 10.1245/s10434-011-1990-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  20 in total

1.  18F-fluorodeoxyglucose uptake of hepatocellular carcinoma as a prognostic predictor in patients with sorafenib treatment.

Authors:  Pil Soo Sung; Hye Lim Park; Keungmo Yang; Seawon Hwang; Myeong Jun Song; Jeong Won Jang; Jong Young Choi; Seung Kew Yoon; Ie Ryung Yoo; Si Hyun Bae
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-10       Impact factor: 9.236

2.  Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.

Authors:  Jeong Won Lee; Sang Hyun Hwang; Hyun Jeong Kim; Dongwoo Kim; Arthur Cho; Mijin Yun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-11       Impact factor: 9.236

3.  A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.

Authors:  Tsung-Han Wu; Etsuro Hatano; Kenya Yamanaka; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Yasuhiro Fujimoto; Takashi Nitta; Masaki Mizumoto; Akira Mori; Hideaki Okajima; Toshimi Kaido; Shinji Uemoto
Journal:  Surg Today       Date:  2016-03-16       Impact factor: 2.549

4.  Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.

Authors:  Shin Hwang; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Sung-Gyu Lee
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

5.  The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients.

Authors:  Shin Hwang; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-05-09       Impact factor: 3.452

6.  18F-Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma as a Useful Predictor of an Extremely Rapid Response to Lenvatinib.

Authors:  Yusuke Kawamura; Masahiro Kobayashi; Junichi Shindoh; Yuta Kobayashi; Kayoko Kasuya; Tomoya Sano; Shunichiro Fujiyama; Tetsuya Hosaka; Satoshi Saitoh; Hitomi Sezaki; Norio Akuta; Fumitaka Suzuki; Yoshiyuki Suzuki; Kenji Ikeda; Yasuji Arase; Masaji Hashimoto; Hiromitsu Kumada
Journal:  Liver Cancer       Date:  2019-11-13       Impact factor: 11.740

7.  Outcomes and recurrence patterns following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging.

Authors:  Changxian Li; Hongwei Wang; Ruixiang Chen; Hui Zhang; Yonghua Xu; Bin Zhang; Yong Li; Changhe Zhang; Yue Yang; Xuehao Wang; Xiangcheng Li
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

8.  Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.

Authors:  Jae Hyun Han; Dong Goo Kim; Gun Hyung Na; Eun Young Kim; Soo Ho Lee; Tae Ho Hong; Young Kyoung You
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.

Authors:  Seung Hyup Hyun; Jae Seon Eo; Jeong Won Lee; Joon Young Choi; Kyung-Han Lee; Sae Jung Na; Il Ki Hong; Jin Kyoung Oh; Yong An Chung; Bong-Il Song; Tae-Sung Kim; Kyung Sik Kim; Dae Hyuk Moon; Mijin Yun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-02       Impact factor: 9.236

10.  Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study.

Authors:  Shin Hwang; Jae-Won Joh; Hee Jung Wang; Dong Goo Kim; Kyung Sik Kim; Kyung-Suk Suh; Seong Hoon Kim; Hee Chul Yu; Chol Kyoon Cho; Young-Joo Lee; Ki-Hun Kim; Jong Man Kim; Bong-Wan Kim; Sung-Gyu Lee
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.